13F-HR filed by Affinity Asset Advisors, LLC
Affinity Asset Advisors, LLC filed this 13F-HR for the quarter ended 2023-12-31, filed 2024-02-13, with 82 holding rows worth $547,527,586.
- Accession
- 0001999371-24-002152
- Filer
- CIK 1773195
- Filed
- 2024-02-13
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2023
A holdings report, 82 entries on the cover page, a total value of $547,527,586 stated on the cover page (in dollars after the unit check, H1), rows summing to $547,527,586 with VALUE read as dollars as filed, 13F file number 028-20754. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| IMMUNOGEN INC | 45253H101 | COMMON STOCK | 1,404,608 | $41,646,627 | dollars as filed | |
| CEREVEL THERAPEUTICS HLDNG I | 15678U128 | COM | 750,000 | $31,800,000 | dollars as filed | |
| CYMABAY THERAPEUTICS INC | 23257D103 | COM | 1,090,441 | $25,756,216 | dollars as filed | |
| MADRIGAL PHARMACEUTICALS INC COM | 558868105 | Stock | 100,000 | $23,138,000 | dollars as filed | |
| XENON PHARMACEUTICALS INC COM | 98420N105 | Stock | 460,000 | $21,187,600 | dollars as filed | |
| BRIDGEBIO PHARMA INC | 10806XAB8 | NOTE 2.500% 3/1 | 17,000,000 | $20,578,500 | dollars as filed | principal |
| TEVA PHARMACEUTICAL INDS LTD SPONSORED ADS | 881624209 | ADR | 1,900,000 | $19,836,000 | dollars as filed | |
| ARCELLX INC COMMON STOCK | 03940C100 | Stock | 340,000 | $18,870,000 | dollars as filed | |
| LIANBIO ADR | 53000N108 | COM | 3,779,694 | $16,895,232 | dollars as filed | |
| CRINETICS PHARMACEUTICALS INC COM | 22663K107 | Stock | 447,095 | $15,907,640 | dollars as filed | |
| CELLDEX THERAPEUTICS INC NEW | 15117B202 | COM NEW | 400,000 | $15,864,000 | dollars as filed | |
| APOGEE THERAPEUTICS INC COM | 03770N101 | Stock | 537,093 | $15,006,378 | dollars as filed | |
| TEVA PHARMACEUTICAL INDS LTD SPONSORED ADS | 881624209 | ADR | 1,400,000 | $14,616,000 | dollars as filed | call |
| IMMUNOVANT INC | 45258J102 | COM | 345,000 | $14,534,850 | dollars as filed | |
| CYTOKINETICS INC | 23282W605 | COM NEW | 160,000 | $13,358,400 | dollars as filed | |
| NUVALENT INC COM | 670703107 | Stock | 175,000 | $12,878,250 | dollars as filed | |
| ASTRIA THERAPEUTICS INC COM | 04635X102 | Stock | 1,466,465 | $11,262,451 | dollars as filed | |
| VERONA PHARMA PLC | 925050106 | SPONSORED ADS | 563,824 | $11,208,821 | dollars as filed | |
| SPYRE THERAPEUTICS INC | 00773J202 | COM NEW | 517,554 | $11,137,762 | dollars as filed | |
| AUTOLUS THERAPEUTICS PLC SPON | 05280R100 | COM | 1,550,408 | $9,984,628 | dollars as filed | |
| ALKERMES PLC | G01767105 | SHS | 356,384 | $9,886,092 | dollars as filed | |
| INOZYME PHARMA INC | 45790W108 | COM | 1,885,802 | $8,033,517 | dollars as filed | |
| EYEPOINT INC COM NEW | 30233G209 | Stock | 320,100 | $7,397,511 | dollars as filed | put |
| NURIX THERAPEUTICS INC | 67080M103 | COMMON STOCK | 690,112 | $7,121,956 | dollars as filed | |
| CENTESSA PHARMACEUTICALS PLC | 152309100 | SPONSORED ADS | 795,729 | $6,334,003 | dollars as filed | |
| ESTABLISHMENT LABS HOLDINGS | G31249108 | COMMON STOCK | 228,277 | $5,910,092 | dollars as filed | |
| MIRATI THERAPEUTICS INC | 60468T105 | COM | 100,049 | $5,877,879 | dollars as filed | |
| ESTABLISHMENT LABS HOLDINGS | G31249108 | COMMON STOCK | 225,000 | $5,825,250 | dollars as filed | call |
| ALNYLAM PHARMACEUTICALS INC COM | 02043Q107 | Stock | 30,000 | $5,742,300 | dollars as filed | call |
| ROIVANT SCIENCES LTD | G76279101 | SHS | 500,000 | $5,615,000 | dollars as filed | |
| VIKING THERAPEUTICS INC | 92686J106 | COM | 300,000 | $5,583,000 | dollars as filed | |
| SAVARA INC | 805111101 | COM | 1,150,000 | $5,405,000 | dollars as filed | |
| COMPASS PATHWAYS PLC | 20451W101 | SPONSORED ADS | 550,000 | $4,812,500 | dollars as filed | |
| APELLIS PHARMACEUTICALS INC | 03753U106 | COM | 75,000 | $4,489,500 | dollars as filed | |
| MOONLAKE IMMUNOTHERAPEUTICS CLASS A ORD | 61559X104 | Stock | 70,988 | $4,286,965 | dollars as filed | |
| DYNAVAX TECHNOLOGIES CORP | 268158201 | COM NEW | 300,000 | $4,194,000 | dollars as filed | |
| STRUCTURE THERAPEUTICS INC COMP | 86366E106 | EQUITY | 100,000 | $4,076,000 | dollars as filed | call |
| ASTRAZENECA PLC SPONSORED ADR | 046353108 | ADR | 60,000 | $4,041,000 | dollars as filed | |
| AXSOME THERAPEUTICS INC. COM | 05464T104 | Stock | 50,000 | $3,979,500 | dollars as filed | |
| SPRINGWORKS THERAPEUTICS INC | 85205L107 | COM | 100,000 | $3,650,000 | dollars as filed | |
| OMEROS CORP | 682143AG7 | NOTE 5.250% 2/1 | 6,000,000 | $3,600,000 | dollars as filed | principal |
| COHERUS BIOSCIENCES INC | 19249HAB9 | BOND | 6,000,000 | $3,403,157 | dollars as filed | principal |
| CRINETICS PHARMACEUTICALS INC COM | 22663K107 | Stock | 94,300 | $3,355,194 | dollars as filed | put |
| RELAY THERAPEUTICS INC COM | 75943R102 | Stock | 300,000 | $3,303,000 | dollars as filed | |
| BRIDGEBIO PHARMA INC | 10806X102 | COM | 80,000 | $3,229,600 | dollars as filed | |
| KRYSTAL BIOTECH INC COM | 501147102 | Stock | 25,000 | $3,101,500 | dollars as filed | |
| CULLINAN THERAPEUTICS INC | 230031106 | COM | 300,000 | $3,057,000 | dollars as filed | |
| TANGO THERAPEUTICS INC | 87583X109 | COM | 300,274 | $2,972,713 | dollars as filed | |
| ARGENX SE SPONSORED ADR | 04016X101 | ADR | 7,500 | $2,853,225 | dollars as filed | |
| KURA ONCOLOGY INC COM | 50127T109 | Stock | 191,535 | $2,754,273 | dollars as filed | |
| FILANA THERAPEUTICS INC | 14817C107 | CMN | 121,000 | $2,723,710 | dollars as filed | call |
| EYEPOINT INC COM NEW | 30233G209 | Stock | 109,900 | $2,539,789 | dollars as filed | |
| ASCENDIS PHARMA A/S DKK 1.0 AD | 04351P101 | SPONSORED ADR | 20,000 | $2,519,000 | dollars as filed | |
| Mersana Therapeutics Inc | 59045L106 | Common Stock | 1,000,000 | $2,320,000 | dollars as filed | |
| IMMATICS N.V | N44445109 | SHS | 200,000 | $2,106,000 | dollars as filed | |
| PENUMBRA INC COM | 70975L107 | Stock | 7,500 | $1,886,550 | dollars as filed | |
| Tourmaline Bio Inc | 89157D105 | Common Stock | 68,081 | $1,782,361 | dollars as filed | |
| ADC THERAPEUTICS SA | H0036K147 | COMMON STOCK | 1,013,540 | $1,682,476 | dollars as filed | |
| VAXCYTE INC COM | 92243G108 | Stock | 25,000 | $1,570,000 | dollars as filed | |
| KALVISTA PHARMACEUTICALS INC | 483497103 | COM | 125,969 | $1,543,120 | dollars as filed | |
| APELLIS PHARMACEUTICALS INC | 03753U106 | COM | 25,000 | $1,496,500 | dollars as filed | call |
| MIRUM PHARMACEUTICALS INC | 604749101 | COM | 50,000 | $1,476,000 | dollars as filed | |
| NEWAMSTERDAM PHARMA CO NV | N62509109 | COMMON STOCK | 125,000 | $1,396,250 | dollars as filed | |
| NEUROCRINE BIOSCIENCES INC | 64125C109 | COM | 10,000 | $1,317,600 | dollars as filed | |
| INARI MED INC | 45332Y109 | COM | 20,000 | $1,298,400 | dollars as filed | |
| ALLOGENE THERAPEUTICS INC | 019770106 | COM | 400,000 | $1,284,000 | dollars as filed | |
| MORPHIC HLDG INC | 61775R105 | COM | 42,670 | $1,232,310 | dollars as filed | |
| VIRIDIAN THERAPEUTICS INC | 92790C104 | COM | 50,000 | $1,089,000 | dollars as filed | |
| BIOHAVEN LTD | G1110E107 | COM | 20,866 | $893,065 | dollars as filed | |
| PUMA BIOTECHNOLOGY INC | 74587V107 | COMMON STOCK | 202,349 | $876,171 | dollars as filed | |
| FULCRUM THERAPEUTICS INC | 359616109 | COMMON STOCK | 125,000 | $843,750 | dollars as filed | |
| ALKERMES PLC | G01767105 | SHS | 27,000 | $748,980 | dollars as filed | put |
| TECTONIC THERAPEUTIC INC COM | 05455M100 | Stock | 500,000 | $680,000 | dollars as filed | |
| IMMATICS N.V | N44445117 | *W EXP 07/01/202 | 187,204 | $546,636 | dollars as filed | |
| NEWAMSTERDAM PHARMA CO NV-27 | N62509117 | WTS | 137,000 | $428,810 | dollars as filed | |
| TERNS PHARMACEUTICALS INC COM | 880881107 | Stock | 66,000 | $428,340 | dollars as filed | |
| NUVATION BIO INC COM CL A | 67080N101 | Stock | 250,000 | $377,500 | dollars as filed | |
| CONTEXT THERAPEUTICS INC | 21077P108 | COM | 328,817 | $371,563 | dollars as filed | |
| Inflarx Nv | N44821101 | COM | 200,097 | $326,158 | dollars as filed | |
| PROMIS NEUROSCIENCES INC | 74346M406 | COM NEW | 265,958 | $305,852 | dollars as filed | |
| Aravive Inc | 03890D108 | Common / Ordinary Stock | 346,511 | $42,863 | dollars as filed | |
| Rocket Pharmaceuticals Inc W Exp 09/02/202 | 77313F114 | Warrant | 75,000 | $36,750 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001999371-24-002152 | this filing | 2024-02-13 | acceptance time not in the bulk data set |